Please use this identifier to cite or link to this item:
|Title:||Recombinant C-terminal fragments of the gastrin-releasing peptide precursor are bioactive.|
|Authors:||Patel, Oneel;Dumesny, Chelsea;Shulkes, Arthur;Baldwin, Graham S|
|Affiliation:||University of Melbourne, Department of Surgery, Austin Health, Heidelberg, Melbourne, VIC, Australia.|
|Citation:||Cancer Letters 2007; 254(1): 87-93|
|Abstract:||C-terminal fragments from the precursor for gastrin-releasing peptide (GRP) have been detected in several human tumour types. We have previously demonstrated that recombinant human proGRP42-98 is biologically active. To investigate the regions responsible, proGRP42-98 was cleaved with thrombin, and the fragments purified by HPLC. Both proGRP42-79 and proGRP80-98 stimulated proliferation of the human colorectal carcinoma cell line DLD-1, but neither peptide bound to the GRP receptor or bombesin receptor subtype 3. We conclude that two distinct regions of the proGRP C-terminus are biologically active, via a receptor distinct from the known GRP receptors. This discovery opens the way for the development of selective antagonists that may offer new therapies for proGRP-producing tumours.|
|Internal ID Number:||17395367|
BALB 3T3 Cells
Cell Line, Tumor
Cell Proliferation.drug effects
Chromatography, High Pressure Liquid
Recombinant Proteins.isolation & purification.metabolism.pharmacology
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.